ENTITY
TIGIT
TIGIT
PulseAugur coverage of TIGIT — every cluster mentioning TIGIT across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
2 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Huayu Pharmaceutical's novel triple-target cancer therapy gains clinical trial approval
Huayu Pharmaceutical's subsidiary, Huayu Haiyue, has received approval from China's National Medical Products Administration to begin clinical trials for HY07121, a novel subcutaneous injection for advanced solid tumors…
-
TIGIT cancer drugs fail to replicate Keytruda's success
The article discusses TIGIT drugs, a class of cancer immunotherapies that have largely failed to deliver on their initial promise. Similar to the disappointing amyloid-beta drugs for Alzheimer's, TIGIT drugs were develo…